Agilent Technologies, Inc.
corporate_fare Company Profile
Agilent Technologies, Inc. (NYSE:A) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for A at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-13, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for A spans 8-K, 10-Q, PRE 14A.
Recent high-impact activity:
- Agilent to Acquire AI Pathology Software Maker Proscia for $240M
- Agilent Beats Q3, Raises FY26 Outlook on Strong Demand
- Agilent Beats Q3, Raises FY26 Guidance on 8% Revenue Growth
- Agilent Guides Q4 Adjusted EPS to $1.71-$1.74, Above Consensus
- EU Approves Agilent's Keytruda Companion Diagnostic for Ovarian Cancer
Financial Snapshot
Short Interest & Short Volume
2.42 days to coverFINRA reported short interest of 5,025,670 shares in A as of the October 15, 2026 settlement, a 4.1% decrease from the prior period — about 2.4 days to cover at its recent average daily volume. On November 5, 2026, 50.7% of A volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.